Author: Press Room

As the war enters its 444th day, we take a look at the main developments.Here is the situation as it stands on Saturday, May 13, 2023. Conflict Moscow acknowledged that its forces had fallen back north of Ukraine’s ruined eastern city of Bakhmut, in a retreat that the head of Russia’s Wagner private army called a “rout”. The Ukrainian military said in a daily update that Russia was focusing its efforts near Lyman, Bakhmut, Avdiivka and Maryinka in eastern Ukraine. “The enemy carried out 36 attacks in these directions in the last 24 hours,” it said. Russian-installed officials in the…

Read More

STOCKHOLM: European Union ministers on Friday (May 12) backed reducing the bloc’s economic dependence on China but will now have to figure out how to make that a reality, foreign policy chief Josep Borrell said. Borrell said foreign ministers gave broad backing to a plan to adjust policy on China to place greater emphasis on its role as a political rival, while continuing also to see Beijing both as a partner on global issues and an economic competitor. “Colleagues welcomed the paper that we presented. They agree on the basic lines of this re-calibration of our strategy on China,” Borrell…

Read More

Love is the most precious thing in this world-it doesn’t know boundaries in the animal kingdom. When it comes to the more advanced human race, it gets sophisticated in such a way that many put a lot of resources in pursuit of love. Indeed, we often try to find love and affection in our lifetime and form our own families with the people we meet. Sometimes it takes more than mere conduct or actions to communicate to the other party our intentions and plans in the long run, but we continue to show what we intend to do or have…

Read More

What I’m reading: summer snobs edition I’ve made a decision that I feel very good about: the theme of my summer fiction reading this year is going to be snobbery.This dovetails with my interest in the ways that status and hierarchies limit political change and fuel backlashes. But snob fiction is the fun, lighthearted cousin: books that focus on the odd habits and eccentric preoccupations of people at the top of a particular status hierarchy, and the wild flailing that results when an outsider tries to gain entry — or an insider tries to escape.I’m enjoying “Pineapple Street,” by Jenny…

Read More

Washington — In the same Washington, D.C., courthouse where the Justice Department has been convening grand juries to investigate former President Donald Trump’s actions around the 2020 presidential election and his handling of classified documents, federal prosecutors managing a separate case were successful Friday in their request to delay a Trump deposition that had been scheduled for later this month in a four-year-old civil lawsuit filed by former FBI officials. Former FBI counterintelligence official Peter Strzok and a one-time attorney at the Bureau, Lisa Page, sued the Justice Department after they were both fired during the federal probe into Russian interference…

Read More

Workers at a rural Georgia factory that builds electric school buses under generous federal subsidies voted to unionize on Friday, handing organized labor and Democrats a surprise victory in their hopes to turn huge new infusions of money from Washington into a union beachhead in the Deep South.The company, Blue Bird in Fort Valley, Ga., may lack the cachet of Amazon or the ubiquity of Starbucks, two other corporations that have attracted union attention. But the 697-to-435 vote by Blue Bird’s workers to join the United Steelworkers was the first significant organizing election at a factory receiving major federal funding…

Read More

Curaleaf (CURA) stock price has been in a strong bearish trend in the past few months as the cannabis sector’s hype evaporates. The shares plunged to a low of $3.30 on Thursday, meaning that they have fallen by over 85% from the all-time high in 2020. In the same period, the Global X Cannabis ETF (POTX) stock has crashed by over 90%. Perils of investing in hype In March, I wrote an article where I warned against the risks of investing in trending areas. At the time, I warned that most hyped artificial intelligence stocks like C3.ai and Guardforce AI…

Read More

AstraZeneca is the jewel in the FTSE 100’s crown. The pharmaceutical group now has a market capitalisation of £182bn. This places it firmly ahead of Shell, the index’s second-largest constituent, with a market cap of £161bn.This might be difficult to believe given oil’s well-documented resurgence in the wake of the war in Ukraine. But it is a testament to the power of both AstraZeneca’s pipeline and its existing portfolio of medicines. The company recently overtook Pfizer in market value terms — a significant milestone given that the US firm attempted a hostile takeover of its UK rival nine years ago.…

Read More

This article is an on-site version of our Moral Money newsletter. Sign up here to get the newsletter sent straight to your inbox.Visit our Moral Money hub for all the latest ESG news, opinion and analysis from around the FT Greetings from New York. I have just returned from Boston, where the mighty Harvard University has been staging its inaugural Climate Action Week in recent days. As Jeremy Grantham, the investment luminary who has long shouted (or thundered) about the risks of climate change, observed in a panel that I moderated, Harvard has been lamentably slow to embrace these issues.…

Read More